MED23 and Hepatic fibrosis: Thus, mice with Med23 deletion in hepatocytes seem to be able to mount augmented immune responses to chronic CCl4 administration, which possibly results in enhanced liver fibrosis and increased compensatory hepatocyte proliferation.